Consun Pharmaceutical Group Limited (1681.HK)
HKD 7.63
(-1.68%)
HKD 7.63
(-1.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.59 Billion | 2.33 Billion | 2.04 Billion | 1.75 Billion | 1.72 Billion | 1.84 Billion |
| Cost of Revenue | 668.43 Million | 576.73 Million | 517.32 Million | 431.15 Million | 466.85 Million | 459.54 Million |
| Gross Profit | 1.92 Billion | 1.76 Billion | 1.52 Billion | 1.32 Billion | 1.26 Billion | 1.38 Billion |
| Operating Expenses | 1.03 Billion | 1.05 Billion | 857.81 Million | 744.42 Million | 1.12 Billion | 756.51 Million |
| Selling, General and Administrative Expenses | 1.16 Billion | 1.06 Billion | 881.95 Million | 775.36 Million | 771.03 Million | 738.06 Million |
| Research and Development Expenses | 108.53 Million | 117.53 Million | 102.16 Million | 83.65 Million | 75.37 Million | 67.93 Million |
| Other Expenses | -239.62 Million | -4.04 Million | 7.87 Million | -3.66 Million | 483 Thousand | 1.04 Million |
| Cost and Expenses | 1.7 Billion | 1.63 Billion | 1.37 Billion | 1.17 Billion | 1.58 Billion | 1.21 Billion |
| Operating Income | 884.96 Million | 715.4 Million | 660.18 Million | 550.12 Million | 496.37 Million | 655.32 Million |
| Interest Expense | 21.26 Million | 10.93 Million | 12.9 Million | 21.4 Million | 29.04 Million | 27.46 Million |
| Income Tax Expense | 77.14 Million | 62.69 Million | 108.74 Million | 101.99 Million | 70.54 Million | 119.2 Million |
| Earnings before Tax | 863.7 Million | 746.39 Million | 695.86 Million | 583.73 Million | 133.66 Million | 616.69 Million |
| Net Income | 784.53 Million | 682.9 Million | 590.17 Million | 498.78 Million | 79.82 Million | 465.35 Million |
| Earnings Per Share Basic | 0.98 | 0.86 | 0.74 | 0.61 | 0.09 | 0.54 |
| Earnings Per Share Diluted | 0.98 | 0.86 | 0.73 | 0.61 | 0.09 | 0.53 |
| Weighted Average Shares Outstanding | 800.54 Million | 790.62 Million | 801.58 Million | 817.26 Million | 848.77 Million | 854.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 799.16 Million | 791.99 Million | 804.7 Million | 817.26 Million | 854.47 Million | 877.98 Million |
| Gross Margin | 0.74 | 0.75 | 0.75 | 0.75 | 0.73 | 0.75 |
| EBIT Margin | 0.37 | 0.34 | 0.36 | 0.35 | 0.33 | 0.39 |
| Profit Margin | 0.30 | 0.29 | 0.29 | 0.28 | 0.05 | 0.25 |
| EBITDA | 963.05 Million | 785.88 Million | 728.71 Million | 618.78 Million | 566.35 Million | 723.7 Million |
| Earnings Before Tax Margin | 0.34 | 0.31 | 0.32 | 0.31 | 0.29 | 0.36 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 1.26 Billion | 1.47 Billion | 2.59 Billion | 1.11 Billion | 1.34 Billion | 2.33 Billion |
| Cost of Revenue | 321.02 Million | 385.17 Million | 668.43 Million | 283.26 Million | 321.3 Million | 576.73 Million |
| Gross Profit | 947.52 Million | 1.08 Billion | 1.92 Billion | 836.41 Million | 1.02 Billion | 1.76 Billion |
| Operating Expenses | 500.19 Million | 585.1 Million | 1.09 Billion | 484.05 Million | 609.94 Million | 1.05 Billion |
| Selling, General and Administrative Expenses | 537.45 Million | 673.97 Million | - | 481.23 Million | 612.04 Million | - |
| Research and Development Expenses | 40.95 Million | 60.57 Million | - | 47.96 Million | 68.45 Million | - |
| Other Expenses | -78.21 Million | -149.43 Million | 3.29 Million | - | - | -4.04 Million |
| Cost and Expenses | 821.21 Million | 970.28 Million | 1.76 Billion | 767.31 Million | 931.24 Million | 1.63 Billion |
| Operating Income | 447.33 Million | 500.15 Million | 884.96 Million | 359.96 Million | 417.94 Million | 715.4 Million |
| Interest Expense | - | - | 21.26 Million | - | - | 10.93 Million |
| Income Tax Expense | 32.99 Million | 47.37 Million | 77.14 Million | 29.77 Million | 48.81 Million | 62.69 Million |
| Earnings before Tax | 433.95 Million | 486.09 Million | 863.7 Million | 377.6 Million | 436.87 Million | 746.39 Million |
| Net Income | 399.76 Million | 436.64 Million | 784.53 Million | 347.89 Million | 386.17 Million | 682.9 Million |
| Earnings Per Share Basic | 0.49 | 0.54 | - | 0.44 | 0.49 | - |
| Earnings Per Share Diluted | 0.49 | 0.54 | - | 0.44 | 0.49 | - |
| Weighted Average Shares Outstanding | 810.88 Million | 804.18 Million | 790.9 Million | 796.64 Million | 792.81 Million | 790.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 810.9 Million | 801.7 Million | 799.16 Million | 796.62 Million | 789.21 Million | 791.99 Million |
| Gross Margin | 0.75 | 0.74 | 0.74 | 0.75 | 0.76 | 0.75 |
| EBIT Margin | 0.36 | 0.34 | - | 0.35 | 0.34 | - |
| Profit Margin | 0.32 | 0.30 | 0.30 | 0.31 | 0.29 | 0.29 |
| EBITDA | 453.5 Million | 501.95 Million | - | 395.55 Million | 451.92 Million | - |
| Earnings Before Tax Margin | 0.35 | 0.34 | 0.34 | 0.32 | 0.31 | 0.31 |
000631
AHK
OFSTF
0GN6
016580
RELI